The company has received final approval for six ANDAs (abbreviated new drug application) and launched four products in the fourth quarter of last fiscal.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fNhMBT
via IFTTT
Aurobindo Pharma plans to launch 50-60 products in US in FY21
The company has received final approval for six ANDAs (abbreviated new drug application) and launched four products in the fourth quarter of last fiscal.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fNhMBT
via IFTTT
0 comments:
Post a Comment